Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Plaxpot Multi Plasma

K-Number: K220493 · 2023-10-27

ApplicantGcs Co. Limited
Decision Date2023-10-27
Product CodeQVJ
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Plaxpot Multi Plasma is a medical device manufactured by Gcs Co. Limited. It received FDA 510(k) clearance on 2023-10-27 under approval number K220493. The device is classified under product code QVJ. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Plaxpot Multi Plasma?

Plaxpot Multi Plasma is a medical device that received FDA 510(k) clearance on 2023-10-27. It is manufactured by Gcs Co. Limited. The 510(k) number is K220493.

When was Plaxpot Multi Plasma approved by the FDA?

Plaxpot Multi Plasma received FDA 510(k) clearance on 2023-10-27, under approval number K220493.

What company makes Plaxpot Multi Plasma?

Plaxpot Multi Plasma is manufactured by Gcs Co. Limited.

What is the FDA product code for Plaxpot Multi Plasma?

The FDA product code for Plaxpot Multi Plasma is QVJ.

Related Clinical Trials

NCT05128513 Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke SUSPENDED

Related Devices (Code: QVJ)

K213247JETT PLASMA Medical IICompex, Spol, S.R.O. K223440Plasma Pen (Plasma MD); Plasma Pen (Plasma +)Plasma Concepts K233760Mjolnir Pro. (Multi–electrode plasma)Shenzhen Leaflife Technology Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑